COMMUNIQUÉS West-GlobeNewswire

iTeos Therapeutics to Present Preclinical Data from A2A Receptor Antagonist and Anti-TIGIT Antibody Programs at AACR
12/04/2018
iTeos Therapeutics to Present Preclinical Data from A 2A Receptor Antagonist and Anti-TIGIT Antibody Programs at AACR Gosselies, Belgium - April 12, 2018 - iTeos Therapeutics SA, a biotechnology company developing novel [...]
Helsinn Provides Grant for ESMO's Preceptorship Programme for Supportive and Palliative Care
12/04/2018
Helsinn Provides Grant for ESMO's Preceptorship Programme for Supportive and Palliative Care Lugano, Switzerland April 12, 2018 - Helsinn, a Swiss pharmaceutical group focused on building quality cancer care products, [...]
Assembly Biosciences Presents Positive Interim Data from Phase 1a and 1b Studies of ABI-H0731 in HBV Patients in a Late-Breaker Session at the EASL Conference
12/04/2018
Robust antiviral activity observed in HBV patients Generally safe and well tolerated Planning underway for Phase 2a studies beginning summer 2018 Company to host conference call on Thursday, April 12 th at 8am ET / 2pm [...]
Medibio finalizes acquisition of Vital Conversations
12/04/2018
SYDNEY, Australia and MINNEAPOLIS, April 12, 2018 (GLOBE NEWSWIRE) -- Medibio Limited ( MEB or the Company ) (ASX:MEB) (OTCQB:MDBIF), a mental health technology company, announces the completion of the acquisition of [...]
Shire plc : Rule 2.9 Announcement
12/04/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 12 April 2018 [...]
CellaVision AB: CellaVision's 2017 Annual report now available
12/04/2018
Today, CellaVision announced that the company's Annual report for 2017 is available as PDF at www.cellavision.com , and can be read via the link below. The company has decided to print CellaVisions 2017 Annual report in [...]
Zealand Pharma will attend the Kempen Life Science Conference on April 18, 2018 in Amsterdam
12/04/2018
Press release - No. 10 / 2018 Zealand Pharma will attend the Kempen Life Science Conference on April 18, 2018 in Amsterdam Copenhagen, April 12, 2018 - Mats Blom, Executive Vice President and Chief Financial Officer ( [...]
Infant Bacterial Therapeutics publishes Annual Report for 2017
12/04/2018
Today, Infant Bacterial Therapeutics AB (publ) publishes the Annual Report for the financial year 2017. The report is available on IBTs website under financial information http://ibtherapeutics.com/investors/financial- [...]
ERYTECH to Present Results from Phase I Trial of eryaspase in ALL and New Pre-clinical Data at AACR 2018
12/04/2018
LYON, France, April 12, 2018 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Euronext Paris:ERYP) (Nasdaq: ERYP ) , a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug [...]
Sensorion reports full year 2017 results
12/04/2018
Increase in operating costs consistent with advancing clinical development of SENS-111 for acute unilateral vestibulopathy (severe vertigo) and SENS-401 for sudden sensorineural hearing loss; Validating deal to study [...]
PUBLICATION IN ACCORDANCE WITH ARTICLE 14 OF THE BELGIAN LAW OF 2 MAY 2007 REGARDING THE PUBLICATION OF MAJOR SHAREHOLDINGS (THE "TRANSPARENCY LAW")
12/04/2018
REGULATED INFORMATION GHENT, Belgium, 12 April 2018 - Ablynx [Euronext Brussels and Nasdaq: ABLX] today announced, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major [...]
TiGenix reports 2017 full year results
12/04/2018
PRESS RELEASE Regulated information inside information TiGenix reports 2017 full year results Leuven (BELGIUM) - April 12, 2018, 7:00h CEST - TiGenix NV (Euronext Brussels and NASDAQ: TIG), an advanced biopharmaceutical [...]
TiGenix présente ses résultats de l'an 2017
12/04/2018
COMMUNIQUÉ DE PRESSE INFORMATIONS RÈGLEMENTÉES INFORMATIONS PRIVILÉGIÉES TiGenix présente ses résultats de l'an 2017 Louvain (BELGIQUE) - 12 avril 2018, 07h00 CEST - TiGenix NV (Euronext Brussels et NASDAQ : TIG), [...]
Sanofi to invest €350 million in Canadian vaccine facility
12/04/2018
Press Release Source: Sanofi (EURONEXT: SAN) (NYSE: SNY) Sanofi to invest €350 million in Canadian vaccine facility Expansion demonstrates company's commitment to innovation and leadership in global public health New [...]
Sanofi va investir 350 millions d'euros dans une unité de production de vaccins au Canada
12/04/2018
Communiqué de presse Source : Sanofi (EURONEXT: SAN) (NYSE: SNY) Sanofi va investir 350 millions d'euros dans une unité de production de vaccins au Canada Un agrandissement qui illustre l'engagement de l'entreprise en [...]
Fagron realises organic turnover growth of 6.8%
12/04/2018
Regulated information Nazareth (Belgium) / Rotterdam (The Netherlands), 12 April 2018 Fagron realises organic turnover growth of 6.8% Key points Organic turnover growth in Europe, South America and North America. Europe [...]
PUBLICATION IN ACCORDANCE WITH ARTICLE 14 OF THE BELGIAN LAW OF 2 MAY 2007 REGARDING THE PUBLICATION OF MAJOR SHAREHOLDINGS (THE "TRANSPARENCY LAW")
12/04/2018
REGULATED INFORMATION GHENT, Belgium, 12 April 2018 - Ablynx [Euronext Brussels and Nasdaq: ABLX] today announced, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major [...]
argenx to receive third preclinical milestone payment from collaboration with LEO Pharma - Milestone associated with CTA approval for ARGX-112
12/04/2018
Breda, the Netherlands/Ghent, Belgium - argenx (Euronext & Nasdaq: ARGX) a clinical-stage biotechnology company developing a deep pipeline of differentiated antibody-based therapies for the treatment of severe [...]
Atea Pharmaceuticals Reports Positive Proof of Concept Clinical Data With AT-527 for the Treatment of Chronic Hepatitis C
12/04/2018
AT-527 is a novel pan-genotypic purine nucleotide prodrug NS5B polymerase inhibitor which has been safe and well tolerated in this ongoing multiple part trial AT-527 exhibits potent antiviral activity in genotype (GT)- [...]

Pages